Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 3-9

  Xia, Weiya ^a   Lau, Yiu Keung ^a   Zhang, Hua Zhong ^a   Liu, Ai Ru ^b   Li, Lei ^b   Kiyokawa, Nobutaka ^a   Clayman, Gary L ^a   Katz, Ruth L ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METASTASIS; MOUTH CARCINOMA; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CHILD; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031041969     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Silverberg, E., Boring, C. C., and Squires, T. S. Cancer statistics 1995. CA Cancer J. Clin., 40: 9-26, 1995.
2. Ries, L. A. G., Hankey, B. T., Miller, B. A., Hartman, A. M., and Edwards, B. K. Cancer Statistics review 1973-88. National Cancer Institute, 1991.
3. Silverman, S. J. Early diagnosis of oral cancer. Cancer (Phila.), 62: 1796-1799, 1988.
4. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth. Nature (Lond.), 319: 226-230, 1986.
5. Bargmann, C. I., Hung, M-C., and Weinberg, R. A. The neu oncogene encodes epidermal growth factor receptor-related protein. Nature (Lond.), 319: 226-230, 1986.
6. Schechter, A. L., Hung, M-C., Vaidyanathan, L., Weinberg, R. A., Yang-Feng, T. L., Francke, U., Ullrich, A., and Coussens, L. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science (Washington DC), 229: 976-978, 1985.
7. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science (Washington DC), 232: 1644-1646, 1986.
8. Coussens, L., Yang-Feng, T. L., Liao, Y-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230: 1132-1139, 1985.
9. Stern, D. F., Heffernan, P. A., and Weinberg, R. A. p185, a product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity. Mol. Cell. Biol., 6: 1729-1740, 1986.
10. Yarden, Y., and Ullrich, A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem., 57: 443-478, 1988.
11. Xie, Y., Pendergast, A. M., and Hung, M-C. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/neu. J. Biol. Chem., 270: 30717-30724, 1995.
12. Xie, Y., Li, K., and Hung, M-C. Tyrosine phosphorylation of She proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH 3T3 cells mediated by the point-mutation activated neu. Oncogene, 10: 2409-2413, 1995.
13. Yu, D., Wang, S-S., Dulski, K. M., Tsai, C-M., Nicolson, G. L. and Hung, M-C. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54: 3260-3266, 1994.
14. neu Expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50: 5184-5191, 1990.
15. Sozzi, G., Miozzo, M., Tagliabue, E., Calderone, C., Lombardi, L., Pilotti, S., Pastorino, U., Pierotti, M. A., and Della Porta, G. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res., 57: 400-404, 1991.
16. Weiner, D. B., Nordberg, J., Robinson, R., Nowell, P. C., Gazdar, A., Greene, M. I., Williams, W. V., Cohen, J. A., and Kern, J. A. Expression of the neu gene-encoded protein (p 185neu) in human non- small cell carcinomas of the lung. Cancer Res., 50: 421-425, 1990.
17. Schneider, P. M., Hung, M-C., Chiocca, S. M., Manning, J., Zhao, X. Y., Fang, K., and Roth, J. A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res., 49: 4968-4971, 1989.
18. Hung, M-C. The neu proto-oncogene and breast cancer. Cancer Bull., 40: 300-303, 1988.
19. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and McGuire, W. L. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
20. Zhang, X., Silva, E., Gershenson, D., and Hung, M-C. Amplification and rearrangement of c-erbB proto-oncogenes in cancer of human female genital tract. Oncogene, 4: 985-989, 1989.
21. Field, J. K., Spandidos, D. A., Yiagisis, M., Gosney, J. R., Papdimitriou, K., and Stell, P. M. c-erb-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res., 12: 613-620, 1992.
22. Craven, J. M., Pavelic, Z. P., Stambrook, P. J., Pavelic, L., Gapany, M., Kelly, D. J., Bapany, S., and Gluckman, J. L. Expression of c-erbB-2 gene in human head and neck carcinoma. Anticancer Res., 12: 2273-2276, 1992.
23. Hou, L., Shi, D., Tu, S-M., Zhang, H-Z., Hung, M-C., and Ling, D. Oral cancer progression and c-erbB-2/new proto-oncogene expression. Cancer Lett., 65: 215-220, 1992.
24. Washi, P. N., Cohen, B., Lutrhra, U. K., and Torloni, H. Histological typing of oral and oropharyngeal tumors. In: International Histological Classification of Tumors, No. 4, pp. 17-18. Geneva: WHO, 1971.
25. Hsu, S. M., and Raine, L. Discovery of a high affinity of phaseolus vulgaris agglutinin (PHA) with gastrosecreting cells. Am J. Clin. Pathol., 77: 396-400, 1982.
26. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
27. Beckhart, R. N., Kiyokawa, N., Xi, L., Liu, T-J., Hung, M-C., El-Naggar, A. K., Zhang, Z-H., and Clayman, G. L. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head & Neck Surg., 121: 1265-1270, 1995.
28. Esteban, J. M., Ahn, C., Mehta, P., and Battifora, H. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. Am. J. Clin. Pathol., 102: 158-162, 1993.
29. Eisbruch, A., Blick, M., Lee, J. S., Sacks, P. G., and Gutterman, J. Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors. Cancer Res., 47: 3603-3605, 1987.
30. Ishitoya, J., Toriyama, M., Oguchi, N., Kitamura, K., Ohsima, M., Asano, K., and Yamamoto, T. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br. J. Cancer, 59: 559-562, 1988.
31. Santini, J., Formento, J. L., Francoual, M., Milano, G., Schneider, M., Dassonville, O., and Demard, F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head & Neck, 13: 132-139, 1991.
32. Gusterson, B. A., Guillick, W. J., Vener, D. J., Powles, T. J., Elliott, C., Ashley, S., Tidy, A., and Harrison, S. Immunohistochemical localization of c-erbB-2 in human breast carcinomas. Br. J. Cancer. 58: 453-457, 1988.
33. De Potter, C. R., Quatacker, J., Maertens, G., Van Daele, S., Pauwels, C., Verhofstede, C., Eechaute, W., and Roels, H. The subcellular localization of the neu protein in human normal and neoplastic cells. Int. J. Cancer, 44: 969-974, 1989.
34. De Potter, C., Beghin, A. P., Makar, D., Vandekerckhove, J., and Roels, H. J. The neu-oncogene protein as predictive factor for haematogenous metastases in breast cancer patients. Int. J. Cancer, 45: 55-58, 1990.
35. Press, M. F., Hung, G., Godolphin, W., and Slamon, D. J. Sensitivity of her-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res., 54: 2771-2777, 1994.
36. neu tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun., 203: 1589-1598, 1994.
37. Marti, U., Burwen, S. J., Wells, A., Barker, M. E., Huling, S., Feren, A. M., and Jones, A. L. Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology, 13: 15-20, 1991.
38. Holt, S. J., Alexander, P., Imman, C. B., and Davies, D. E. Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associatied with translocation of epidermal growth factor receptor into the nucleus. Biochemical Pharmacol., 47: 117-126, 1994.
39. Katoh, M., Yazaki, Y., Sugimura, T., and Terada, M. c-erbB-3 gene encodes secreted as well as transmembrane receptor tyrosine kinase. Biochem. Biophys. Res. Commun., 192: 1189-1197, 1993.
40. neu levels in HER-2/neu-transfected human lung cancer cells. J. Natl. Cancer Inst., 87: 682-684, 1995.